Who invested in EBlu Solutions

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$4.0Mraised across 1 round since 2024, from 1 source

Latest round: Venture, $4.0MJan 2024
Investors: 1

See who backed them

The rounds

Jan 2024
Venture$4.0M
- FCA Venture Partners
Source recordedSEC filing: $4.0M sold, first sale Jan 2024

Founders and team

From EBlu Solutions's own website and the SEC filings it signed: 12 on the team.

Willis ChandlerPresident and Chief Executive Officer
Alexis RosePresident of 3PL and Marketing and Samples Management
Champ BurgessPresident of Pharmacy Services
Mark MurphyPresident of Patient Access Solutions
Ben ByfordChief Information Officer
Eric JohnsonChief Growth Officer, Marketing and Sample Management
Harold TamayoChief Financial Officer
Katherine TamulonisGeneral Counsel and Chief Compliance Officer
Matt WolfChief Commercial Officer
Tony CallanderChief Human Resource Officer
Kim FarleyExecutive Officeri
Nathan FornwaltExecutive Officeri

On the board, as filediLance HillMichael DavisRobert SaundersRoger KobelThomas HearnWilliam Trainor

Everyone who backed them

FCA Venture PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists EBlu Solutions as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.